UTIC course has been awarded a FIP Seal

UTIC (Understanding targeted therapies and immunotherapies for cancer) course has been awarded a FIP Seal. This is a joint collaboration between BOPA and ISOPP.

The FIP Seal for programmes is awarded to professional development programmes and courses and provides a visible signal of the alignment of a provider of programmes with the FIP mission to advance pharmacy worldwide. It also provides an external signal of solidarity and trust as the provider of programmes assures quality of their programmes and courses through a self-assessment criteria. For more information on FIP or the FIP seal click here: https://provision.fip.org/fip-seal/ 

This is a FREE course for BOPA free associates or PAID members and ISOPP members (no-fee) to access via their websites.

Latest News

By BOPA on 20th January 2025

Monographs for use of immunosuppressants in Immune-related adverse events (irAEs)

The Immune-Related Adverse Effects that arise from use of checkpoint inhibitors can be difficult to manage, especially when steroids are not enough. Despite there being guidance about how to manage…

Read article
By BOPA on 17th January 2025

SAVE THE DATE: The 28th BOPA Annual Conference

Here is an important date for your diaries: The 28th British Oncology Pharmacy Association (BOPA) Annual Conference, 3-5 October 2025, ICC Belfast   The conference will include an exciting variety…

Read article
By BOPA Digital Subcommittee on 10th January 2025

BOPA Digital Subcommittee – new members required

The BOPA digital subcommittee are looking for new members. The primary purpose of the BOPA digital subcommittee is to promote excellence in the pharmaceutical care of patients by supporting membership…

Read article
By BOPA Education & Training Subcommittee on 8th January 2025

Opportunity for a pharmacist to review the eLearning content for Chronic Lymphocytic Leukaemia

The Education and Training Subcommittee are in the process of updating the eLearning content on the BOPA website. As part of this update, we are looking for an experienced pharmacist to review…

Read article